Treatment with Tumor necrosis factor alpha (TNF-α), known to decrease barrier tightness, significantly increased dextran leakage, confirming the model’s responsiveness to neuroinflammation, a common hallmark of NDD. This evidence concerns the gene TNF and Neurodevelopmental delay.